| 000 | 01334nam a22004455i 4500 | ||
|---|---|---|---|
| 001 | 978-0-387-23695-7 | ||
| 003 | DE-He213 | ||
| 005 | 20130515020401.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2005 xxu| s |||| 0|eng d | ||
| 020 |
_a9780387236957 _9978-0-387-23695-7 |
||
| 024 | 7 |
_a10.1007/b102187 _2doi |
|
| 050 | 4 | _aRM1-950 | |
| 072 | 7 |
_aMMG _2bicssc |
|
| 072 | 7 |
_aMED071000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615 _223 |
| 100 | 1 | _aLos, Marek. | |
| 245 | 1 | 0 |
_aApoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases _h[electronic resource] / _cedited by Marek Los, Spencer B. Gibson. |
| 260 |
_aBoston, MA : _bSpringer US, _c2005. |
||
| 300 | _bdigital. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aOncology. | |
| 650 | 0 | _aHuman genetics. | |
| 650 | 0 | _aImmunology. | |
| 650 | 0 | _aToxicology. | |
| 650 | 0 | _aCytology. | |
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 650 | 2 | 4 | _aCancer Research. |
| 650 | 2 | 4 | _aCell Biology. |
| 650 | 2 | 4 | _aImmunology. |
| 650 | 2 | 4 | _aHuman Genetics. |
| 700 | 1 | _aGibson, Spencer B. | |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9780387233840 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/b102187 |
| 912 | _aZDB-2-SBL | ||
| 999 |
_c65798 _d65798 |
||